Companies’ Global Health ‘Footprint’: Could Rating Help?
Imagine a rating or accreditation system for companies' "global health footprint." Such a system would rigorously assess companies' overall impact on human health, including the health of the world's poorest and sickest populations, then disseminate this information in ways that users could readily understand and act upon. If successful, such a system would inform and enhance choice for ethically-minded corporate executives, board members, investors, business partners, workers, consumers, and regulators.
Bringing together leaders and experts in ethics, global health, business, law, communication, and health-related quality and safety certification, this conference discussed dilemmas, shared best practices, and sought to identify forms of global health impact monitoring and labeling that could be affordable, rigorous, reliable, sensitive to community needs, and user-friendly.
The full conference agenda and videos of the event are available here.
Nir Eyal, Associate Professor of Global Health and Social Medicine
Jennifer Miller, Edmond J. Safra Lab Fellow
Co-sponsored by Edmond J. Safra Center for Ethics at Harvard University; the Division of Medical Ethics at Harvard Medical School; the Harvard Global Health Institute; and the Petrie-Flom Center, with support from the Oswald DeN. Cammann Fund.